Start Date
June 30, 2020
Primary Completion Date
July 31, 2021
Study Completion Date
December 31, 2021
Ruxolitinib
For patients unable to swallow pills, a ruxolitinib suspension will be administered through a nasogastric/orogastric tube
Peripheral blood draw
-Screening, Day 2, Day 4, Day 8, Day 15, and Day 29
Collaborators (1)
Incyte Corporation
INDUSTRY
Washington University School of Medicine
OTHER